{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:23:40Z","timestamp":1775546620613,"version":"3.50.1"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>OBJECTIVE. The objective of this study was to analyze the population incidence of retinopathy of prematurity treatment in Denmark in the 10-year period from 1996 to 2005.<\/jats:p><jats:p>METHODS. Patient charts of infants treated for retinopathy of prematurity and the national birth registry provide information about neonatal parameters. These parameters, along with birth in the latter half of the period (2001\u20132005), were analyzed as risk factors for retinopathy of prematurity. The national registry for blind and visually impaired children was accessed to obtain information about visual impairment attributable to retinopathy of prematurity in both treated and untreated infants.<\/jats:p><jats:p>RESULTS. The study population consisted of 5467 Danish preterm infants born in 1996 to 2005, with a gestational age of &amp;lt;32 weeks, who survived for \u22655 postnatal weeks; 2616 were born in 1996 to 2000, and 2851 were born in 2001 to 2005. The incidence of treated retinopathy of prematurity cases increased significantly from 1.3% in 1996 to 2000 to 3.5% in 2001 to 2005. Significant risk factors for retinopathy of prematurity treatment were low gestational age, small for gestational age, male gender, and multiple birth. Other, yet unknown factors contributed to the increased incidence in the latter half of the period. Of the study population, 0.6% were registered as visually impaired because of retinopathy of prematurity within 2 years after birth (early-detected visual impairment). The incidences were not significantly different between 1996 to 2000 and 2001 to 2005. Of all of the early-detected, visually impaired children, 16% had not been treated for retinopathy of prematurity and were considered screening failures.<\/jats:p><jats:p>CONCLUSIONS. The incidence of retinopathy of prematurity treatment in Denmark has more than doubled during the past half-decade. This increase could not be fully explained by increased survival rates for the infants or by changes in the investigated neonatal risk factors.<\/jats:p>","DOI":"10.1542\/peds.2007-0644","type":"journal-article","created":{"date-parts":[[2007,12,31]],"date-time":"2007-12-31T17:23:13Z","timestamp":1199121793000},"page":"97-105","source":"Crossref","is-referenced-by-count":41,"title":["Treatment for Retinopathy of Prematurity in Denmark in a Ten-Year Period (1996\u20132005): Is the Incidence Increasing?"],"prefix":"10.1542","volume":"121","author":[{"given":"Carina","family":"Slidsborg","sequence":"first","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Bom","family":"Olesen","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Koch","family":"Jensen","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Jensen","sequence":"additional","affiliation":[{"name":"Neonatology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamilla Rothe","family":"Nissen","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorm","family":"Greisen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"National Board of Health, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Call\u00f8","family":"Fledelius","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"la Cour","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"},{"name":"Neonatology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"2021120902195510400_R1","doi-asserted-by":"crossref","unstructured":"Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics.\u20082005;115(5). Available at: www.pediatrics.org\/cgi\/content\/full\/115\/5\/e518","DOI":"10.1542\/peds.2004-1180"},{"key":"2021120902195510400_R2","doi-asserted-by":"crossref","unstructured":"Chiang MF, Arons RR, Flynn JT, Starren JB. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York State patient database. Ophthalmology.\u20082004;111:1317\u20131325","DOI":"10.1016\/j.ophtha.2003.10.030"},{"key":"2021120902195510400_R3","doi-asserted-by":"crossref","unstructured":"Larsson E, Carle-Petrelius B, Cernerud G, Ots L, Wallin A, Holmstrom G. Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol.\u20082002;86:1122\u20131126","DOI":"10.1136\/bjo.86.10.1122"},{"key":"2021120902195510400_R4","doi-asserted-by":"crossref","unstructured":"Todd DA, Wright A, Smith J, NICUS Group. Severe retinopathy of prematurity in infants &lt;30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002. Arch Dis Child Fetal Neonatal Ed.\u20082007;92:F251\u2013F254","DOI":"10.1136\/adc.2006.096479"},{"key":"2021120902195510400_R5","doi-asserted-by":"crossref","unstructured":"Hameed B, Shyamanur K, Kotecha S, et al. Trends in the incidence of severe retinopathy of prematurity in a geographically defined population over a 10-year period. Pediatrics.\u20082004;113:1653\u20131657","DOI":"10.1542\/peds.113.6.1653"},{"key":"2021120902195510400_R6","doi-asserted-by":"crossref","unstructured":"Coats DK, Paysse EA, Steinkuller PG. Threshold retinopathy of prematurity in neonates less than 25 weeks' estimated gestational age. J AAPOS.\u20082000;4:183\u2013185","DOI":"10.1016\/S1091-8531(00)70011-5"},{"key":"2021120902195510400_R7","unstructured":"Larsen T. Intrauterine growth restriction: identification, correlation and causation evaluated by use of ultrasound. Dan Med Bull.\u20082001;48:256\u2013274"},{"key":"2021120902195510400_R8","doi-asserted-by":"crossref","unstructured":"Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr.\u20081996;85:843\u2013848","DOI":"10.1111\/j.1651-2227.1996.tb14164.x"},{"key":"2021120902195510400_R9","doi-asserted-by":"crossref","unstructured":"Rudanko SL, Fellman V, Laatikainen L. Visual impairment in children born prematurely from 1972 through 1989. Ophthalmology.\u20082003;110:1639\u20131645","DOI":"10.1016\/S0161-6420(03)00498-6"},{"key":"2021120902195510400_R10","doi-asserted-by":"crossref","unstructured":"Termote J, Schalij-Delfos NE, Donders AR, Cats BP. The incidence of visually impaired children with retinopathy of prematurity and their concomitant disabilities. J AAPOS.\u20082003;7:131\u2013136","DOI":"10.1067\/mpa.2003.S1091853102420083"},{"key":"2021120902195510400_R11","doi-asserted-by":"crossref","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol.\u20081988;106:471\u2013479","DOI":"10.1001\/archopht.1988.01060130517027"},{"key":"2021120902195510400_R12","doi-asserted-by":"crossref","unstructured":"Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial. Arch Ophthalmol.\u20082003;121:1684\u20131694","DOI":"10.1001\/archopht.121.12.1684"},{"key":"2021120902195510400_R13","doi-asserted-by":"crossref","unstructured":"Haugen OH, Markestad T. Incidence of retinopathy of prematurity (ROP) in the western part of Norway: a population-based retrospective study. Acta Ophthalmol Scand.\u20081997;75:305\u2013307","DOI":"10.1111\/j.1600-0420.1997.tb00780.x"},{"key":"2021120902195510400_R14","doi-asserted-by":"crossref","unstructured":"Ahmed MA, Duncan M, Kent A. Incidence of retinopathy of prematurity requiring treatment in infants born greater than 30 weeks' gestation and with a birthweight greater than 1250 g from 1998 to 2002: a regional study. J Paediatr Child Health.\u20082006;42:337\u2013340","DOI":"10.1111\/j.1440-1754.2006.00868.x"},{"key":"2021120902195510400_R15","doi-asserted-by":"crossref","unstructured":"Mathew MR, Fern AI, Hill R. Retinopathy of prematurity: are we screening too many babies?Eye.\u20082002;16:538\u2013542","DOI":"10.1038\/sj.eye.6700031"},{"key":"2021120902195510400_R16","doi-asserted-by":"crossref","unstructured":"Chow LC, Wright KW, Sola A. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?Pediatrics.\u20082003;111:339\u2013345","DOI":"10.1542\/peds.111.2.339"},{"key":"2021120902195510400_R17","doi-asserted-by":"crossref","unstructured":"Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore.\u20082005;34:169\u2013178","DOI":"10.47102\/annals-acadmedsg.V34N2p169"},{"key":"2021120902195510400_R18","doi-asserted-by":"crossref","unstructured":"Fledelius HC, Gote H, Greisen G, Jensen H. Surveillance for retinopathy of prematurity in a Copenhagen high-risk sample 1999\u20132001: has progress reached a plateau?Acta Ophthalmol Scand.\u20082004;82:32\u201337","DOI":"10.1046\/j.1600-0420.2003.00198.x"},{"key":"2021120902195510400_R19","doi-asserted-by":"crossref","unstructured":"Blair BM, O'Halloran HS, Pauly TH, Stevens JL. Decreased incidence of retinopathy of prematurity, 1995\u20131997. J AAPOS.\u20082001;5:118\u2013122","DOI":"10.1067\/mpa.2001.113843"},{"key":"2021120902195510400_R20","doi-asserted-by":"crossref","unstructured":"Bullard SR, Donahue SP, Feman SS, Sinatra RB, Walsh WF. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS.\u20081999;3:46\u201352","DOI":"10.1016\/S1091-8531(99)70094-7"},{"key":"2021120902195510400_R21","doi-asserted-by":"crossref","unstructured":"Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989\u20131997. Pediatrics.\u20081999;104(3). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/3\/e26","DOI":"10.1542\/peds.104.3.e26"},{"key":"2021120902195510400_R22","doi-asserted-by":"crossref","unstructured":"Todd D, Cassell C, Kennedy J, John E. Retinopathy of prematurity in infants &lt;32 weeks' gestation at birth in New South Wales in 1993 and 1994. J Paediatr Child Health.\u20081999;35:355\u2013357","DOI":"10.1046\/j.1440-1754.1999.00368.x"},{"key":"2021120902195510400_R23","doi-asserted-by":"crossref","unstructured":"Yang MB, Donovan EF, Wagge JR. Race, gender, and Clinical Risk Index for Babies (CRIB) score as predictors of severe retinopathy of prematurity. J AAPOS.\u20082006;10:253\u2013261","DOI":"10.1016\/j.jaapos.2006.01.004"},{"key":"2021120902195510400_R24","doi-asserted-by":"crossref","unstructured":"Nodgaard H, Andreasen H, Hansen H, Sorensen HT. Risk factors associated with retinopathy of prematurity (ROP) in northern Jutland, Denmark 1990\u20131993. Acta Ophthalmol Scand.\u20081996;74:306\u2013310","DOI":"10.1111\/j.1600-0420.1996.tb00098.x"},{"key":"2021120902195510400_R25","doi-asserted-by":"crossref","unstructured":"Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology.\u20081993;100:230\u2013237","DOI":"10.1016\/S0161-6420(93)31665-9"},{"key":"2021120902195510400_R26","doi-asserted-by":"crossref","unstructured":"Darlow BA, Huchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics.\u20082005;115:990\u2013996","DOI":"10.1542\/peds.2004-1309"},{"key":"2021120902195510400_R27","doi-asserted-by":"crossref","unstructured":"Bardin C, Zelkowitz P, Papageorgiou A. Outcome of small-for-gestational age and appropriate-for-gestational age infants born before 27 weeks of gestation. Pediatrics.\u20081997;100(2). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/2\/e4","DOI":"10.1542\/peds.100.2.e4"},{"key":"2021120902195510400_R28","doi-asserted-by":"crossref","unstructured":"Allegaert K, Vanhole C, Casteels I, Naulaers G, Debeer A, Cossey V, et al. Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity. J AAPOS.\u20082003;7:34\u201337","DOI":"10.1067\/mpa.2003.S1091853102420150"},{"key":"2021120902195510400_R29","unstructured":"Fledelius HC, Scherfig E, de la Cour M. Therapy-requiring retinopathy of prematurity in Denmark: a comparison of cryotherapy and laser therapy [in Danish]. Ugeskr Laeger.\u20082004;166;4360\u20134362"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/1\/97\/1122506\/zpe00108000097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/1\/97\/1122506\/zpe00108000097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T21:51:56Z","timestamp":1708465916000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/1\/97\/71031\/Treatment-for-Retinopathy-of-Prematurity-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,1]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0644","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}